KR20160080815A - 올리고뉴클레오티드 프로브 및 이의 용도 - Google Patents

올리고뉴클레오티드 프로브 및 이의 용도 Download PDF

Info

Publication number
KR20160080815A
KR20160080815A KR1020167007928A KR20167007928A KR20160080815A KR 20160080815 A KR20160080815 A KR 20160080815A KR 1020167007928 A KR1020167007928 A KR 1020167007928A KR 20167007928 A KR20167007928 A KR 20167007928A KR 20160080815 A KR20160080815 A KR 20160080815A
Authority
KR
South Korea
Prior art keywords
disease
oligonucleotides
cancer
oligonucleotide
disorder
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
KR1020167007928A
Other languages
English (en)
Korean (ko)
Inventor
데이비드 스페츨러
발레리 도멘유크
니안큉 샤오
아담 스타크
지엔유 중
Original Assignee
카리스 라이프 사이언스 스위스 홀딩스 게엠베하
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 카리스 라이프 사이언스 스위스 홀딩스 게엠베하 filed Critical 카리스 라이프 사이언스 스위스 홀딩스 게엠베하
Publication of KR20160080815A publication Critical patent/KR20160080815A/ko
Ceased legal-status Critical Current

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1034—Isolating an individual clone by screening libraries
    • C12N15/1048—SELEX
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/115—Aptamers, i.e. nucleic acids binding a target molecule specifically and with high affinity without hybridising therewith ; Nucleic acids binding to non-nucleic acids, e.g. aptamers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/5308—Immunoassay; Biospecific binding assay; Materials therefor for analytes not provided for elsewhere, e.g. nucleic acids, uric acid, worms, mites
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/10—Type of nucleic acid
    • C12N2310/16—Aptamers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2525/00—Reactions involving modified oligonucleotides, nucleic acids, or nucleotides
    • C12Q2525/10—Modifications characterised by
    • C12Q2525/205—Aptamer
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/112—Disease subtyping, staging or classification
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Analytical Chemistry (AREA)
  • Pathology (AREA)
  • Biophysics (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Medicinal Chemistry (AREA)
  • Plant Pathology (AREA)
  • Oncology (AREA)
  • Hospice & Palliative Care (AREA)
  • General Physics & Mathematics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Computational Biology (AREA)
KR1020167007928A 2013-08-28 2014-08-28 올리고뉴클레오티드 프로브 및 이의 용도 Ceased KR20160080815A (ko)

Applications Claiming Priority (21)

Application Number Priority Date Filing Date Title
US201361871107P 2013-08-28 2013-08-28
US61/871,107 2013-08-28
US201361874621P 2013-09-06 2013-09-06
US61/874,621 2013-09-06
US201361900975P 2013-11-06 2013-11-06
US61/900,975 2013-11-06
US201361912471P 2013-12-05 2013-12-05
US61/912,471 2013-12-05
US201461924192P 2014-01-06 2014-01-06
US61/924,192 2014-01-06
US201461949216P 2014-03-06 2014-03-06
US61/949,216 2014-03-06
US201461974949P 2014-04-03 2014-04-03
US61/974,949 2014-04-03
US201461990085P 2014-05-07 2014-05-07
US61/990,085 2014-05-07
US201461994704P 2014-05-16 2014-05-16
US61/994,704 2014-05-16
US201462024436P 2014-07-14 2014-07-14
US62/024,436 2014-07-14
PCT/US2014/053306 WO2015031694A2 (en) 2013-08-28 2014-08-28 Oligonucleotide probes and uses thereof

Publications (1)

Publication Number Publication Date
KR20160080815A true KR20160080815A (ko) 2016-07-08

Family

ID=52587490

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020167007928A Ceased KR20160080815A (ko) 2013-08-28 2014-08-28 올리고뉴클레오티드 프로브 및 이의 용도

Country Status (10)

Country Link
US (2) US20160319361A1 (cg-RX-API-DMAC7.html)
EP (1) EP3039174B1 (cg-RX-API-DMAC7.html)
JP (1) JP2016533752A (cg-RX-API-DMAC7.html)
KR (1) KR20160080815A (cg-RX-API-DMAC7.html)
CN (1) CN105980615A (cg-RX-API-DMAC7.html)
AU (2) AU2014312211A1 (cg-RX-API-DMAC7.html)
BR (1) BR112016004153A2 (cg-RX-API-DMAC7.html)
CA (1) CA2922689A1 (cg-RX-API-DMAC7.html)
IL (2) IL244236A0 (cg-RX-API-DMAC7.html)
WO (1) WO2015031694A2 (cg-RX-API-DMAC7.html)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20190135456A (ko) * 2016-11-02 2019-12-06 김성천 차세대서열결정법을 이용한 표적 단백질의 집단적 정량 방법과 그 용도

Families Citing this family (60)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9599611B2 (en) 2005-04-25 2017-03-21 Trustees Of Boston University Structured substrates for optical surface profiling
US10942184B2 (en) 2012-10-23 2021-03-09 Caris Science, Inc. Aptamers and uses thereof
KR20150090072A (ko) 2012-10-23 2015-08-05 카리스 라이프 사이언스 스위스 홀딩스 게엠베하 압타머 및 이의 용도
AU2013361323B2 (en) 2012-12-19 2018-09-06 Caris Science, Inc. Compositions and methods for aptamer screening
WO2015092020A2 (en) * 2013-12-20 2015-06-25 Université de Lausanne Diagnostic, prognostic and therapeutic uses of long noncoding rnas for heart disease and regenerative medicine
EP3194979B1 (en) * 2014-09-17 2021-12-22 Wallac OY Method for determining the risk of preterm birth
US20180066262A1 (en) 2015-03-09 2018-03-08 Caris Science, Inc. Oligonucleotide probes and uses thereof
US10772859B2 (en) 2015-05-21 2020-09-15 Indiana University Research And Technology Corporation Methods of targeting APE/Ref-1 to inhibit hypoxia signaling genes
AU2016287499B2 (en) 2015-06-29 2022-08-04 Caris Science, Inc. Therapeutic oligonucleotides
US10941176B2 (en) 2015-07-28 2021-03-09 Caris Science, Inc. Therapeutic oligonucleotides
EP3353528B1 (en) 2015-09-22 2023-11-29 Trustees of Boston University Multiplexed phenotyping of nanovesicles
WO2017112921A1 (en) * 2015-12-24 2017-06-29 The Arizona Board Of Regents On Behalf Of The University Of Arizona Systems and methods for characterizing sepsis
AU2017214541B2 (en) 2016-02-05 2024-03-21 NanoView Biosciences, Inc. Detection of exosomes having surface markers
WO2017161357A1 (en) 2016-03-18 2017-09-21 Caris Science, Inc. Oligonucleotide probes and uses thereof
SG10201911917WA (en) 2016-05-02 2020-01-30 Encodia Inc Macromolecule analysis employing nucleic acid encoding
WO2017205686A1 (en) 2016-05-25 2017-11-30 Caris Science, Inc. Oligonucleotide probes and uses thereof
MA45496A (fr) 2016-06-17 2019-04-24 Hoffmann La Roche Molécules d'acide nucléique pour la réduction de l'arnm de padd5 ou pad7 pour le traitement d'une infection par l'hépatite b
WO2018081193A1 (en) * 2016-10-25 2018-05-03 Purdue Research Foundation Conjugates for sensing
CN110913910A (zh) * 2017-05-08 2020-03-24 奥曼尼提纳米有限公司 快速进化的生物实体的治疗
CN110662844A (zh) 2017-05-22 2020-01-07 内盖夫生物技术国家研究所有限公司 用于肺癌的诊断的生物标志物
AU2018281196B2 (en) 2017-06-07 2022-04-28 Gen-Probe Incorporated Detecting Babesia species nucleic acid in a sample
CN109251980A (zh) * 2017-07-14 2019-01-22 中国人民解放军第八医院 膀胱癌组织t细胞图谱模型及其构建方法和构建系统
JP2019020206A (ja) * 2017-07-14 2019-02-07 株式会社島津製作所 質量分析を用いた認知機能障害疾患バイオマーカーの定量方法及び質量分析装置
KR102243415B1 (ko) * 2017-09-27 2021-04-22 ㈜로제타엑소좀 크기 배제 크로마토그래피를 이용한 세포밖 소포체의 분석 방법 및 이의 용도
RU2766360C2 (ru) 2017-10-16 2022-03-15 Ф. Хоффманн-Ля Рош Аг МОЛЕКУЛЫ НУКЛЕИНОВЫХ КИСЛОТ ДЛЯ УМЕНЬШЕНИЯ УРОВНЯ мРНК PAPD5 ИЛИ PAPD7 ДЛЯ ЛЕЧЕНИЯ ИНФЕКЦИОННОГО ГЕПАТИТА В
CA3081441C (en) 2017-10-31 2023-08-29 Encodia, Inc. Kits for analysis using nucleic acid encoding and/or label
CN108866215B (zh) * 2017-12-01 2022-02-08 苏州百源基因技术有限公司 一种用于产气肠杆菌检测的实时荧光定量pcr试剂盒
WO2019155050A1 (en) * 2018-02-12 2019-08-15 F. Hoffmann-La Roche Ag Method of predicting response to therapy by assessing tumor genetic heterogeneity
GB201810571D0 (en) * 2018-06-27 2018-08-15 Cs Genetics Ltd Reagents and methods for the analysis of circulating microparticles
CA3103054A1 (en) 2018-07-03 2020-01-09 F. Hoffmann-La Roche Ag Oligonucleotides for modulating tau expression
JP7434276B2 (ja) * 2018-07-26 2024-02-20 ブラッコ・イメージング・ソシエタ・ペル・アチオニ Ｉｃａｍ－１アプタマー、その診断および治療用途
US12331320B2 (en) 2018-10-10 2025-06-17 The Research Foundation For The State University Of New York Genome edited cancer cell vaccines
US11608356B1 (en) * 2019-02-22 2023-03-21 Base Pair Biotechnologies, Inc. Functional ligands to colistin
EP3931351B1 (en) * 2019-03-01 2024-09-11 Mercy Bioanalytics, Inc. Method for target entity detection using ligase
CN109880903B (zh) * 2019-03-01 2021-12-14 南京医科大学 一种用于非小细胞肺癌辅助诊断的snp标志物及其应用
CN110045099B (zh) * 2019-04-01 2022-03-04 四川大学华西医院 一种慢性阻塞性肺疾病检测试剂盒
BR112021020411A2 (pt) * 2019-04-11 2022-03-15 Univ Arkansas Aptâmeros de dna específicos para cd40 como adjuvantes de vacina
WO2020219923A1 (en) * 2019-04-26 2020-10-29 The Johns Hopkins University Methods and materials for treating cancer
CA3138367A1 (en) 2019-04-30 2020-11-05 Encodia, Inc. Methods for preparing analytes and related kits
CN110412281B (zh) * 2019-06-26 2022-09-09 四川大学华西医院 Begain自身抗体检测试剂在制备肺癌筛查试剂盒中的用途
WO2021076808A1 (en) * 2019-10-15 2021-04-22 Cornell University Methods for detecting and inhibiting brain metastasis
WO2021183893A1 (en) * 2020-03-13 2021-09-16 The Translational Genomics Research Institute Methods and kits for the detection of sars-cov-2
EP4150080A4 (en) * 2020-05-15 2025-11-19 Codex Dna Inc On-demand synthesis of polynucleotide sequences
CN111621588A (zh) * 2020-06-08 2020-09-04 华中农业大学 光亮果皮番茄品种选育的分子标记及其应用
CA3176605A1 (en) 2020-06-25 2021-12-30 The Procter & Gamble Company Aptamers for personal health care applications
CN111830289B (zh) * 2020-07-24 2023-01-03 长春理工大学 一种利用原子力显微术对生物素化抗体-IgE免疫复合物直接成像的方法
US20230272490A1 (en) * 2020-08-07 2023-08-31 The Board Of Trustees Of The University Of Arkansas Nasal microbiome biomarkers for predicting the onset of bovine respiratory disease and treating the same
JP7623124B2 (ja) * 2020-10-20 2025-01-28 大塚製薬株式会社 細胞外小胞の内包物の測定方法および測定キット
CN112535886B (zh) * 2020-11-12 2022-07-12 杭州苏铂科技有限公司 去除金纳米棒溶液中的ctab的方法
IL307421A (en) 2021-04-08 2023-12-01 Arrowhead Pharmaceuticals Inc Rnai agents for inhibiting expression of receptor for advanced glycation end-products, compositions thereof, and methods of use
WO2023028035A1 (en) * 2021-08-23 2023-03-02 University Of Florida Research Foundation, Incorporated Lipid enveloped recombinant aav particles for gene therapy use
CN117451995A (zh) * 2021-12-06 2024-01-26 上海市精神卫生中心（上海市心理咨询培训中心） 用于预测应激后精神心理症状发生的免疫检测试剂盒及应用
CN114410773B (zh) * 2022-01-27 2024-05-03 宁波大学 用于预测或诊断抑郁症复发的标志物组合及其应用
CN114438191B (zh) * 2022-01-27 2024-04-30 宁波大学 缺氧诱导因子1α作为标志物在抑郁症复发诊断中的应用
EP4526040A1 (en) * 2022-05-18 2025-03-26 Bio-Rad Laboratories, Inc. System and method for automated digital polymerase chain reaction
CN115754293A (zh) * 2022-11-07 2023-03-07 四川大学华西第二医院 Vwf糖基化蛋白的检测试剂在制备筛查患肺癌风险的试剂盒中的用途
CN120435568A (zh) * 2022-11-17 2025-08-05 普瓦捷大学 用于确定微卫星不稳定性状态的方法、试剂盒及其用途
WO2024229467A2 (en) * 2023-05-04 2024-11-07 The Trustees Of The University Of Pennsylvania Detection of tumor-derived nucleic acids using red blood cells
CN117230203B (zh) * 2023-11-14 2024-02-06 首都医科大学附属北京儿童医院 检测myod1基因突变的引物探针组及其试剂盒
CN119959532B (zh) * 2025-01-03 2025-11-11 中国科学院精密测量科学与技术创新研究院 细胞色素c在制备elisa试剂盒方面的新用途

Family Cites Families (137)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4275149A (en) 1978-11-24 1981-06-23 Syva Company Macromolecular environment control in specific receptor assays
US4551435A (en) 1983-08-24 1985-11-05 Immunicon, Inc. Selective removal of immunospecifically recognizable substances from solution
US4666828A (en) 1984-08-15 1987-05-19 The General Hospital Corporation Test for Huntington's disease
US4683202A (en) 1985-03-28 1987-07-28 Cetus Corporation Process for amplifying nucleic acid sequences
US4801531A (en) 1985-04-17 1989-01-31 Biotechnology Research Partners, Ltd. Apo AI/CIII genomic polymorphisms predictive of atherosclerosis
US4737456A (en) 1985-05-09 1988-04-12 Syntex (U.S.A.) Inc. Reducing interference in ligand-receptor binding assays
US4795698A (en) 1985-10-04 1989-01-03 Immunicon Corporation Magnetic-polymer particles
US4925788A (en) 1986-10-24 1990-05-15 Immunicon Corporation Immunoassay system and procedure based on precipitin-like interaction between immune complex and Clq or other non-immunospecific factor
US5158871A (en) 1988-02-12 1992-10-27 University Of Connecticut Method of using magnetic particles for isolating, collecting and assaying diagnostic ligates
US5108933A (en) 1988-09-16 1992-04-28 Immunicon Corporation Manipulation of colloids for facilitating magnetic separations
US5272057A (en) 1988-10-14 1993-12-21 Georgetown University Method of detecting a predisposition to cancer by the use of restriction fragment length polymorphism of the gene for human poly (ADP-ribose) polymerase
US5800992A (en) * 1989-06-07 1998-09-01 Fodor; Stephen P.A. Method of detecting nucleic acids
US5192659A (en) 1989-08-25 1993-03-09 Genetype Ag Intron sequence analysis method for detection of adjacent and remote locus alleles as haplotypes
SE470347B (sv) 1990-05-10 1994-01-31 Pharmacia Lkb Biotech Mikrostruktur för vätskeflödessystem och förfarande för tillverkning av ett sådant system
DE69128350T2 (de) 1990-06-11 1998-03-26 Nexstar Pharmaceuticals Inc Nukleinsäureliganden
US5861254A (en) 1997-01-31 1999-01-19 Nexstar Pharmaceuticals, Inc. Flow cell SELEX
US5648214A (en) 1990-06-11 1997-07-15 University Research Corporation High-affinity oligonucleotide ligands to the tachykinin substance P
US6011020A (en) 1990-06-11 2000-01-04 Nexstar Pharmaceuticals, Inc. Nucleic acid ligand complexes
US5580737A (en) 1990-06-11 1996-12-03 Nexstar Pharmaceuticals, Inc. High-affinity nucleic acid ligands that discriminate between theophylline and caffeine
US5660985A (en) 1990-06-11 1997-08-26 Nexstar Pharmaceuticals, Inc. High affinity nucleic acid ligands containing modified nucleotides
US5683867A (en) 1990-06-11 1997-11-04 Nexstar Pharmaceuticals, Inc. Systematic evolution of ligands by exponential enrichment: blended SELEX
US5707796A (en) 1990-06-11 1998-01-13 Nexstar Pharmaceuticals, Inc. Method for selecting nucleic acids on the basis of structure
US5705337A (en) 1990-06-11 1998-01-06 Nexstar Pharmaceuticals, Inc. Systematic evolution of ligands by exponential enrichment: chemi-SELEX
US5763177A (en) 1990-06-11 1998-06-09 Nexstar Pharmaceuticals, Inc. Systematic evolution of ligands by exponential enrichment: photoselection of nucleic acid ligands and solution selex
US5496938A (en) 1990-06-11 1996-03-05 Nexstar Pharmaceuticals, Inc. Nucleic acid ligands to HIV-RT and HIV-1 rev
US5270163A (en) 1990-06-11 1993-12-14 University Research Corporation Methods for identifying nucleic acid ligands
US5567588A (en) 1990-06-11 1996-10-22 University Research Corporation Systematic evolution of ligands by exponential enrichment: Solution SELEX
US5637459A (en) 1990-06-11 1997-06-10 Nexstar Pharmaceuticals, Inc. Systematic evolution of ligands by exponential enrichment: chimeric selex
US5200084A (en) 1990-09-26 1993-04-06 Immunicon Corporation Apparatus and methods for magnetic separation
DE552178T1 (de) 1990-10-12 1994-02-03 Max Planck Gesellschaft Abgeänderte ribozyme.
US6582908B2 (en) * 1990-12-06 2003-06-24 Affymetrix, Inc. Oligonucleotides
US5186827A (en) 1991-03-25 1993-02-16 Immunicon Corporation Apparatus for magnetic separation featuring external magnetic means
US5541061A (en) 1992-04-29 1996-07-30 Affymax Technologies N.V. Methods for screening factorial chemical libraries
US5817635A (en) 1993-08-09 1998-10-06 Max-Planck-Gesellschaft Zur Forderung Der Wissenschaften E.V. Modified ribozymes
US5736330A (en) 1995-10-11 1998-04-07 Luminex Corporation Method and compositions for flow cytometric determination of DNA sequences
US5612473A (en) 1996-01-16 1997-03-18 Gull Laboratories Methods, kits and solutions for preparing sample material for nucleic acid amplification
KR100514929B1 (ko) 1996-10-25 2005-09-15 길리애드 사이언시즈, 인코포레이티드 혈관내피 성장인자 핵산 리간드 복합체
US6051698A (en) 1997-06-06 2000-04-18 Janjic; Nebojsa Vascular endothelial growth factor (VEGF) nucleic acid ligand complexes
JP4357112B2 (ja) 1997-10-14 2009-11-04 ルミネックス コーポレイション 精密蛍光染色された粒子及びその製造及び使用方法
US6719868B1 (en) 1998-03-23 2004-04-13 President And Fellows Of Harvard College Methods for fabricating microfluidic structures
US6406921B1 (en) 1998-07-14 2002-06-18 Zyomyx, Incorporated Protein arrays for high-throughput screening
US6357601B1 (en) 1998-12-04 2002-03-19 Orbital Biosciences Llc Ultrafiltration device and method of forming same
US6623526B1 (en) 1999-01-08 2003-09-23 Corin Limited Knee prosthesis
FR2788780B1 (fr) 1999-01-27 2001-03-30 Ap Cells Inc Procede de preparation de vesicules membranaires
US6811668B1 (en) 1999-06-22 2004-11-02 Caliper Life Sciences, Inc. Apparatus for the operation of a microfluidic device
US6899137B2 (en) 1999-06-28 2005-05-31 California Institute Of Technology Microfabricated elastomeric valve and pump systems
EP1194693B1 (en) 1999-06-28 2006-10-25 California Institute Of Technology Microfabricated elastomeric valve and pump systems
US7195670B2 (en) 2000-06-27 2007-03-27 California Institute Of Technology High throughput screening of crystallization of materials
US7144616B1 (en) 1999-06-28 2006-12-05 California Institute Of Technology Microfabricated elastomeric valve and pump systems
US7501245B2 (en) 1999-06-28 2009-03-10 Helicos Biosciences Corp. Methods and apparatuses for analyzing polynucleotide sequences
US6929030B2 (en) 1999-06-28 2005-08-16 California Institute Of Technology Microfabricated elastomeric valve and pump systems
AUPQ147799A0 (en) 1999-07-07 1999-07-29 Medvet Science Pty. Ltd. Mesenchymal precursor cell
US20030204075A9 (en) * 1999-08-09 2003-10-30 The Snp Consortium Identification and mapping of single nucleotide polymorphisms in the human genome
GB9927320D0 (en) 1999-11-18 2000-01-12 Chiron Spa Exosome separation
AU2001232805A1 (en) 2000-01-12 2001-07-24 Ut-Battelle, Llc A microfluidic device and method for focusing, segmenting, and dispensing of a fluid stream
US7452713B2 (en) 2000-02-29 2008-11-18 Stmicroelectronics S.R.L. Process for manufacturing a microfluidic device with buried channels
US7867763B2 (en) 2004-01-25 2011-01-11 Fluidigm Corporation Integrated chip carriers with thermocycler interfaces and methods of using the same
AU4989501A (en) 2000-04-06 2001-10-23 Luminex Corp Magnetically-responsive microspheres
US6812023B1 (en) 2000-04-27 2004-11-02 Anosys, Inc. Methods of producing membrane vesicles
US6645432B1 (en) 2000-05-25 2003-11-11 President & Fellows Of Harvard College Microfluidic systems including three-dimensionally arrayed channel networks
EP1311854A2 (en) 2000-08-23 2003-05-21 Imego AB Microfuidic device and method with trapping of sample in carities having lids that can be opened or closed
US20020048534A1 (en) 2000-08-24 2002-04-25 David Storek Sample preparing arrangement and a method relating to such an arrangement
US6822454B2 (en) 2000-12-01 2004-11-23 Protasis Corporation Microfluidic device with multiple microcoil NMR detectors and field gradient focusing
US7323140B2 (en) 2001-03-28 2008-01-29 Handylab, Inc. Moving microdroplets in a microfluidic device
US6802342B2 (en) 2001-04-06 2004-10-12 Fluidigm Corporation Microfabricated fluidic circuit elements and applications
US20050158708A1 (en) 2001-06-06 2005-07-21 Iris Alroy Methods and compositions related to tagging of membrane surface proteins
US7390463B2 (en) 2001-09-07 2008-06-24 Corning Incorporated Microcolumn-based, high-throughput microfluidic device
DE60237289D1 (de) 2001-09-17 2010-09-23 Gyros Patent Ab Einen kontrollierten strom in einer mikrofluidvorrichtung ermöglichende funktionseinheit
US7189580B2 (en) 2001-10-19 2007-03-13 Wisconsin Alumni Research Foundation Method of pumping fluid through a microfluidic device
US7253003B2 (en) 2001-10-19 2007-08-07 Wisconsin Alumni Research Foundation Method for monitoring the environment within a microfluidic device
WO2003048295A1 (en) 2001-11-30 2003-06-12 Fluidigm Corporation Microfluidic device and methods of using same
US7691333B2 (en) 2001-11-30 2010-04-06 Fluidigm Corporation Microfluidic device and methods of using same
WO2003048736A2 (en) 2001-12-05 2003-06-12 University Of Washington Microfluidic device and surface decoration process for solid phase affinity binding assays
US7238255B2 (en) 2001-12-31 2007-07-03 Gyros Patent Ab Microfluidic device and its manufacture
US6958119B2 (en) 2002-02-26 2005-10-25 Agilent Technologies, Inc. Mobile phase gradient generation microfluidic device
US7195986B1 (en) 2002-03-08 2007-03-27 Caliper Life Sciences, Inc. Microfluidic device with controlled substrate conductivity
GB2388189B (en) 2002-04-29 2006-01-11 Robert Jeffrey Geddes Carr Optical detection and analysis of particles
US7189581B2 (en) 2002-04-30 2007-03-13 Wisconsin Alumni Research Foundation Method of obtaining a sample concentration of a solution in a microfluidic device
DE60228685D1 (de) 2002-05-16 2008-10-16 Micronit Microfluidics Bv Verfahren zur Herstellung eines mikrofluidischen Bauteiles
AU2003251935A1 (en) 2002-07-15 2004-02-02 James Madison University Hybrid polymers for functional tuning of microfluidic device surfaces
US7201881B2 (en) 2002-07-26 2007-04-10 Applera Corporation Actuator for deformable valves in a microfluidic device, and method
US7452509B2 (en) 2002-07-26 2008-11-18 Applied Biosystems Inc. Microfluidic device including displaceable material trap, and system
US7135147B2 (en) 2002-07-26 2006-11-14 Applera Corporation Closing blade for deformable valve in a microfluidic device and method
KR100480338B1 (ko) 2002-08-08 2005-03-30 한국전자통신연구원 극소량의 유체제어를 위한 미세 유체제어소자
TW536524B (en) 2002-09-17 2003-06-11 Fan-Gen Tzeng Network-type micro-channel device for micro-fluid
US7118661B2 (en) 2002-09-30 2006-10-10 The Regents Of The University Of California Nanolaminate microfluidic device for mobility selection of particles
WO2004034016A2 (en) 2002-10-04 2004-04-22 Noo Li Jeon Microfluidic multi-compartment device for neuroscience research
FR2848125B1 (fr) 2002-12-04 2006-06-09 Commissariat Energie Atomique Dispositif microfluidique dans lequel l'interface liquide/fluide est stabilisee
US7467928B2 (en) 2002-12-12 2008-12-23 Board Of Trustees Of The University Of Arkansas Microfluidic device utilizing magnetohydrodynamics and method for fabrication thereof
US7125711B2 (en) 2002-12-19 2006-10-24 Bayer Healthcare Llc Method and apparatus for splitting of specimens into multiple channels of a microfluidic device
US7338637B2 (en) 2003-01-31 2008-03-04 Hewlett-Packard Development Company, L.P. Microfluidic device with thin-film electronic devices
US7413709B2 (en) 2003-02-12 2008-08-19 Agilent Technologies, Inc. PAEK-based microfluidic device with integrated electrospray emitter
JP3856763B2 (ja) 2003-03-11 2006-12-13 財団法人川村理化学研究所 マイクロ流体素子の製造方法
AU2004228678A1 (en) 2003-04-03 2004-10-21 Fluidigm Corp. Microfluidic devices and methods of using same
US20050145496A1 (en) 2003-04-03 2005-07-07 Federico Goodsaid Thermal reaction device and method for using the same
US7476363B2 (en) 2003-04-03 2009-01-13 Fluidigm Corporation Microfluidic devices and methods of using same
US7604965B2 (en) 2003-04-03 2009-10-20 Fluidigm Corporation Thermal reaction device and method for using the same
US7422725B2 (en) 2003-05-01 2008-09-09 Enplas Corporation Sample handling unit applicable to microchip, and microfluidic device having microchips
CA2528208A1 (en) 2003-06-06 2004-12-16 Micronics, Inc. System and method for heating, cooling and heat cycling on microfluidic device
FR2862007B1 (fr) 2003-11-12 2005-12-23 Commissariat Energie Atomique Dispositif microfluidique muni d'un nez d'electronebulisation.
US7329391B2 (en) 2003-12-08 2008-02-12 Applera Corporation Microfluidic device and material manipulating method using same
EP1547688A1 (en) 2003-12-23 2005-06-29 STMicroelectronics S.r.l. Microfluidic device and method of locally concentrating electrically charged substances in a microfluidic device
US7099778B2 (en) 2003-12-30 2006-08-29 Caliper Life Sciences, Inc. Method for determining diffusivity and molecular weight in a microfluidic device
US7351380B2 (en) 2004-01-08 2008-04-01 Sandia Corporation Microfluidic structures and methods for integrating a functional component into a microfluidic device
MXPA06008399A (es) 2004-01-25 2008-03-07 Fluidigm Corp Dispositivos formadores de cristal y sistemas y metodos para hacer y utilizar los mismos.
US7402229B2 (en) 2004-03-31 2008-07-22 Intel Corporation Fabrication and use of semipermeable membranes and gels for the control of electrolysis in a microfluidic device
EP1744986A2 (en) 2004-04-02 2007-01-24 Eksigent Technologies, LLC Microfluidic device
US7419639B2 (en) 2004-05-12 2008-09-02 The Board Of Trustees Of The Leland Stanford Junior University Multilayer microfluidic device
EP1754257B1 (en) 2004-06-07 2013-12-25 Fluidigm Corporation Optical lens system and method for microfluidic devices
JP2008523354A (ja) 2004-11-17 2008-07-03 ルミネックス・コーポレーション フロー・アナライザからデータを管理するための装置と方法
US7488596B2 (en) 2004-12-17 2009-02-10 Samsung Electronics Co., Ltd. Microfluidic device comprising electrolysis device for cell lysis and method for electrochemically lysing cells using the same
EP1880197B1 (en) 2005-04-12 2019-06-12 Caliper Life Sciences, Inc. Microfluidic device for use with a compact optical detection system
KR100590581B1 (ko) 2005-05-10 2006-06-19 삼성전자주식회사 미세유동장치 및 그 제조방법
JP4992201B2 (ja) 2005-06-07 2012-08-08 富士ゼロックス株式会社 マイクロ流体制御方法、マイクロ流体素子およびその製造方法
TWI274040B (en) 2005-12-23 2007-02-21 Ind Tech Res Inst Microfluidic device and method of manufacturing the same
US7568399B2 (en) 2006-01-05 2009-08-04 Integrated Sensing Systems, Inc. Microfluidic device
US7581429B2 (en) 2006-01-06 2009-09-01 Integrated Sensing Systems, Inc. Microfluidic device and method of operation
US8124015B2 (en) 2006-02-03 2012-02-28 Institute For Systems Biology Multiplexed, microfluidic molecular assay device and assay method
WO2007103572A2 (en) 2006-03-09 2007-09-13 Aethlon Medical, Inc. Extracorporeal removal of microvesicular particles
EP2099930B1 (en) 2006-12-13 2015-02-18 Luminex Corporation Systems and methods for multiplex analysis of pcr in real time
US8008019B2 (en) 2007-11-28 2011-08-30 Luminex Molecular Diagnostics Use of dual-tags for the evaluation of genomic variable repeat regions
US9193968B2 (en) * 2008-03-12 2015-11-24 Aptamatrix, Inc. Library compositions and methods for acyclic identification of aptamers
WO2010062706A2 (en) * 2008-10-30 2010-06-03 Caris Mpi, Inc. Methods for assessing rna patterns
WO2011109440A1 (en) * 2010-03-01 2011-09-09 Caris Life Sciences Luxembourg Holdings Biomarkers for theranostics
EP2730662A1 (en) * 2008-11-12 2014-05-14 Caris Life Sciences Luxembourg Holdings Methods and systems of using exosomes for determining phenotypes
WO2010065765A2 (en) 2008-12-04 2010-06-10 Aethlon Medical, Inc. Affinity capture of circulating biomarkers
EP2202522A1 (en) 2008-12-23 2010-06-30 Universiteit Leiden Methods for immobilizing microvesicles, means and methods for detecting them, and uses thereof
EP3722810A3 (en) 2009-02-11 2021-01-13 Caris MPI, Inc. Molecular profiling of tumors
US20120077263A1 (en) 2009-06-05 2012-03-29 Mayo Foundation For Medical Education And Research Methods and materials for isolating exosomes
CA2779223A1 (en) 2009-10-27 2011-05-12 Caris Mpi, Inc. Molecular profiling for personalized medicine
CA2782284A1 (en) * 2009-11-30 2011-06-03 Caris Life Sciences Luxembourg Holdings, S.A.R.L. Methods and systems for isolating, storing, and analyzing vesicles
WO2011088226A2 (en) * 2010-01-13 2011-07-21 Caris Life Sciences Luxembourg Holdings Detection of gastrointestinal disorders
WO2011106376A2 (en) * 2010-02-23 2011-09-01 The General Hospital Corporation Use of microvesicles in the treatment of medical conditions
US9469876B2 (en) 2010-04-06 2016-10-18 Caris Life Sciences Switzerland Holdings Gmbh Circulating biomarkers for metastatic prostate cancer
JP2014519340A (ja) 2011-06-16 2014-08-14 カリス ライフ サイエンシズ ルクセンブルク ホールディングス エス．アー．エール．エル． バイオマーカー組成物および方法
CN103874770A (zh) 2011-08-08 2014-06-18 卡里斯生命科学卢森堡控股有限责任公司 生物标志物组合物和方法
CA2892490A1 (en) 2012-11-26 2014-05-30 Caris Science, Inc. Biomarker compositions and methods

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20190135456A (ko) * 2016-11-02 2019-12-06 김성천 차세대서열결정법을 이용한 표적 단백질의 집단적 정량 방법과 그 용도

Also Published As

Publication number Publication date
EP3039174A4 (en) 2017-09-27
WO2015031694A3 (en) 2015-06-04
EP3039174B1 (en) 2019-10-16
IL269693A (en) 2019-11-28
IL244236A0 (en) 2016-04-21
CN105980615A (zh) 2016-09-28
US20160319361A1 (en) 2016-11-03
EP3039174A2 (en) 2016-07-06
AU2019200115A1 (en) 2019-01-31
JP2016533752A (ja) 2016-11-04
US20210062270A1 (en) 2021-03-04
AU2014312211A1 (en) 2016-03-10
BR112016004153A2 (pt) 2019-09-17
CA2922689A1 (en) 2015-03-05
WO2015031694A2 (en) 2015-03-05

Similar Documents

Publication Publication Date Title
KR20160080815A (ko) 올리고뉴클레오티드 프로브 및 이의 용도
JP7442483B2 (ja) アプタマーおよびその使用
AU2016229076A1 (en) Oligonucleotide probes and uses thereof
AU2013361323B2 (en) Compositions and methods for aptamer screening
Zhou et al. Integrated microfluidic device for accurate extracellular vesicle quantification and protein markers analysis directly from human whole blood
Hu et al. Potentiality of exosomal proteins as novel cancer biomarkers for liquid biopsy
US20220290124A1 (en) Oligonucleotide probes and uses thereof
JP6404824B2 (ja) 循環腫瘍細胞のインビトロでの捕捉および解析
EP3577127A1 (en) Targeted oligonucleotides
KR20140076543A (ko) 암에 대한 순환하는 생물지표들
WO2017161357A1 (en) Oligonucleotide probes and uses thereof
US20190310172A1 (en) Profiling extracellular vesicles
CA2782284A1 (en) Methods and systems for isolating, storing, and analyzing vesicles
KR20140067001A (ko) 생물지표 조성물 및 방법
JP2014519340A (ja) バイオマーカー組成物および方法
Oey et al. Application of extracellular vesicles in the diagnosis and treatment of prostate cancer: Implications for clinical practice
EP3201353B1 (en) A method of identifying or producing an aptamer
Murray et al. Quantitative proteomic profiling of pleomorphic human sarcoma identifies CLIC1 as a dominant pro-oncogenic receptor expressed in diverse sarcoma types
EP3268476B1 (en) Oligonucleotide probes and uses thereof
Bonacquisti Engineering a Genetically-Encodable Toolkit for Tracking EVs and Their RNA Cargo

Legal Events

Date Code Title Description
PA0105 International application

Patent event date: 20160325

Patent event code: PA01051R01D

Comment text: International Patent Application

PG1501 Laying open of application
PN2301 Change of applicant

Patent event date: 20180928

Comment text: Notification of Change of Applicant

Patent event code: PN23011R01D

PA0201 Request for examination

Patent event code: PA02012R01D

Patent event date: 20190828

Comment text: Request for Examination of Application

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

Comment text: Notification of reason for refusal

Patent event date: 20201207

Patent event code: PE09021S01D

E601 Decision to refuse application
PE0601 Decision on rejection of patent

Patent event date: 20210215

Comment text: Decision to Refuse Application

Patent event code: PE06012S01D

Patent event date: 20201207

Comment text: Notification of reason for refusal

Patent event code: PE06011S01I